Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Two pathways lead to a complex capable of activating C4 and ...

Class:IdSummation:1428511
_displayNameTwo pathways lead to a complex capable of activating C4 and ...
_timestamp2013-05-28 07:32:40
created[InstanceEdit:1428510] Jupe, S, 2011-07-07
literatureReference[LiteratureReference:166769] The biological functions of MBL-associated serine proteases (MASPs)
[LiteratureReference:981688] The human complement system: assembly of the classical pathway C3 convertase
[LiteratureReference:2855089] Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease
[LiteratureReference:166709] The lectin-complement pathway--its role in innate immunity and evolution
modified[InstanceEdit:1428514] Jupe, S, 2011-07-07
[InstanceEdit:3301220] Shamovsky, V, 2013-04-22
[InstanceEdit:3301223] Shamovsky, V, 2013-04-22
[InstanceEdit:3621850] Shamovsky, V, 2013-05-24
[InstanceEdit:3632872] Shamovsky, V, 2013-05-28
textTwo pathways lead to a complex capable of activating C4 and C2.

The classical pathway is triggered by activation of the C1-complex, which consists of hexameric molecule C1q and a tetramer comprising two C1r and two C1s serine proteinases. This occurs when C1q binds to IgM or IgG complexed with antigens, a single IgM can initiate the pathway while multiple IgGs are needed, or when C1q binds directly to the surface of the pathogen. Binding leads to conformational changes in C1q, activating the serine protease activity of C1r, which then cleaves C1s, another serine protease. The C1r:C1s component is now capable of splitting C4 and C2 to produce the classical C3-convertase C4b2a. C1r and C1s are additionally controlled by C1-inhibitor.(Kerr MA 1980)
The lectin pathway is similar in operation but has different components.

Mannose-binding lectin (MBL) or ficolins (L-ficolin, M-ficolin and H-ficolin) initiate the lectin pathway cascade by binding to specific carbohydrate patterns on pathogenic cell surfaces. MBL and ficolins circulate in plasma in complexes with homodimers of MBL-associated serine proteases (MASP) (Fujita et al. 2004; Hajela et al. 2002). Upon binding of human lectin (MBL or ficolins) to the target surface the complex of lectin:MASP undergoes conformational changes, which results in the activation of MASPs by cleavage (Matsushita M et al. 2000; Fujita et al. 2004). Activated MASPs become capable of C4 and C2 cleavage, giving rise to the same C3 convertase C4b:C2a as the classical pathway.

(summation)[Pathway:166786] Creation of C4 and C2 activators [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Two pathways lead to a complex capable of activating C4 and ... (1428511)